Clinical Trial Update: Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gabapentin extended-release (G-ER) for vasomotor symptoms (hot flashes) in postmenopausal women has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes

Drugs mentioned

• Gabapentin Extended Release (G-ER) (gabapentin extended-release)

Snippet

Sponsor: Depomed | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED | Results posted: 2012-02-17